DAWN

Day One Biopharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Vasconcelles MichaelHead Of Research And Dev.
$32k2.7k shares
SellFeb 17, 2026
$11.60
--
Bender JeremyDirector, Officer: CHIEF EXECUTIVE OFFICER
$179k15.5k shares
SellFeb 17, 2026
$11.60
--
York Charles N IICOO And CFO
$70k6.1k shares
SellFeb 17, 2026
$11.60
--
Dubow AdamGen Counsel & Secretary
$74k6.4k shares
SellFeb 17, 2026
$11.60
--
Merendino LaurenChief Commercial Officer
$67k5.8k shares
SellFeb 17, 2026
$11.60
--

News

prnewswire.comServier completes the acquisition of Day One Biopharmaceuticalsprnewswire.comApr 23prnewswire.comAre WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?prnewswire.comApr 9defenseworld.netDay One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?defenseworld.netApr 7businesswire.comDay One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWNbusinesswire.comMar 26